Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Huebner, J. and Oberneder, R. and Baier, M. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R.
(2011)
A phase II study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and low-dose Treosulfan: Final results of a combined anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC).
ONKOLOGIE, 34 (Suppl6).
p. 10.
ISSN 0378-584X
Full text not available from this repository.
Actions (login required)
|
View Item |